Where does Cure Medical LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cure Medical LLC ranks #11,613 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cure Medical LLC hold?

Cure Medical LLC holds 26 US utility patents granted between 2017 and 2023, spanning 8 technology areas.

What is Cure Medical LLC's Innovation Score?

Cure Medical LLC has an Innovation Score of 33.9 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cure Medical LLC's patent grant rate increasing or decreasing?

Cure Medical LLC's recent grant velocity is +17% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Cure Medical LLC's patents?

Cure Medical LLC's patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cure Medical LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cure Medical LLC

Q: What technology areas does Cure Medical LLC focus on?

Cure Medical LLC's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 25 patents, ranking #287 of 3,490 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 26 granted patents across 8 technology areas, recorded in grant years 2017–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cure ranks #11,613 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 8 technology areas.

#11,613
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (33.9/100): 16.9
avg claims per patent: +17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11613 · US Corporation #11,613 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,613/49,997
PHOTO-FINISH Comeup Industries
CPC-NARROW A61M · 8 areas
INNOV-THIN 33.9/100
CLAIMS-RICH 16.9 claims/avg
TYPE-USCORP US Corporation
VEL-UP +17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Comeup Industries Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cure’s 33.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (34%) Velocity 2.4 pts (7%) Breadth 10.0 pts (29%) Claim depth 10.1 pts (30%)

Qualcomm Incorporated · highest

85
CEM · near

34
Cure Medical · this assignee

34
NewAge Products · near

34
Praj Industries · near

34
UD Trucks · near

34
3D Lighting… · lowest

7

What this shows Cure's Innovation Score is 33.9/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cure?

Each dot is one of Cure’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cure’s own 16.9 claims/patent is at or below the 17.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cure vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cure's grants concentrate

Cure Medical LLC is a focused PatentsView assignee: 8 CPC subclasses with 96.2% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2018. By volume, Cure sits between Comeup Industries Inc. and Dell International L.L.C..

Cure's three-year grant acceleration

Cure Medical LLC shows 5 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Comeup Industries

26
Con Edison Batter…

26
Concepts Nrec

26
Coty

26
D-box

26
D Swarovski KG

26
D3 Innovation

26
Dell Internationa…

26
Cure Medical ◀

26

What this shows Cure holds 26 patents at rank #11,613, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cure

By rank, the assignees closest to #11,613 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Cure's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cure, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Cure ranks #287 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

UD Trucks Corporation 34 CEM Corporation 34 NewAge Products Inc. 34 Praj Industries Limited 34

Cure's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Cure Medical LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	6	23.1%
2018	1	3.8%
2019	5	19.2%
2020	5	19.2%
2021	4	15.4%
2022	3	11.5%
2023	2	7.7%

Which technologies does Cure Medical LLC patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 25

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 4

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 1

F16B - Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing 1

F16M - Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports 1

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cure Medical LLC's patent record in context - here's where to go next.

Cure Medical LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 96.2% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #11,613 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cure Medical LLC against Comeup Industries Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.